علاج الورم السحائي الدماغي عندما لا يتوفر أي خيار علاجي موضعي آخر

References

DOI: 10.1093/neuonc/noab150

Pharmacotherapy using bevacizumab or multikinase inhibitors targeting VEGF receptors should only be considered if no further local treatment option exists.

The best albeit modest results with pharmacotherapy have been obtained with bevacizumab or multikinase inhibitors targeting vascular endothelial growth factor receptor, but no standard of care systemic treatment has been yet defined.